Group One Trading’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-152,400
Closed -$15.5M 7938
2025
Q4
$15.5M Buy
152,400
+19,400
+15% +$1.56M 0.03% 681
2025
Q3
$7.28M Buy
133,000
+3,300
+3% +$165K 0.01% 1158
2025
Q2
$6.89M Buy
129,700
+38,800
+43% +$1.97M 0.02% 1082
2025
Q1
$3.94M Sell
90,900
-67,800
-43% -$3.43M 0.01% 1266
2024
Q4
$8.92M Buy
158,700
+4,400
+3% +$274K 0.02% 774
2024
Q3
$10.5M Buy
154,300
+86,300
+127% +$4.87M 0.03% 595
2024
Q2
$2.87M Sell
68,000
-41,000
-38% -$2.26M 0.01% 1173
2024
Q1
$7.53M Buy
109,000
+44,600
+69% +$2.82M 0.03% 574
2023
Q4
$4.76M Buy
64,400
+1,000
+2% +$65.5K 0.01% 1184
2023
Q3
$4.33M Buy
63,400
+3,000
+5% +$255K 0.01% 1035
2023
Q2
$5.67M Buy
60,400
+1,100
+2% +$85.8K 0.02% 864
2023
Q1
$4.02M Sell
59,300
-104,200
-64% -$6.7M 0.01% 979
2022
Q4
$8.09M Buy
163,500
+21,500
+15% +$878K 0.02% 860
2022
Q3
$4.61M Buy
142,000
+39,500
+39% +$1.63M 0.01% 1226
2022
Q2
$4.04M Buy
102,500
+18,000
+21% +$963K 0.01% 1462
2022
Q1
$5.91M Sell
84,500
-154,500
-65% -$11.3M 0.01% 1415
2021
Q4
$18.6M Sell
239,000
-51,600
-18% -$4.55M 0.01% 720
2021
Q3
$27.7M Buy
290,600
+98,000
+51% +$10.3M 0.03% 469
2021
Q2
$23.9M Sell
192,600
-22,300
-10% -$2.66M 0.03% 535
2021
Q1
$28.3M Sell
214,900
-15,300
-7% -$2.09M 0.04% 396
2020
Q4
$30.5M Buy
230,200
+131,600
+133% +$15.9M 0.05% 305
2020
Q3
$10.1M Sell
98,600
-97,600
-50% -$8.43M 0.03% 520
2020
Q2
$17.1M Buy
196,200
+31,300
+19% +$2.5M 0.08% 265
2020
Q1
$9.56M Sell
164,900
-437,000
-73% -$35.5M 0.08% 267
2019
Q4
$55.7M Buy
601,900
+391,600
+186% +$34.4M 0.38% 27
2019
Q3
$19M Buy
210,300
+67,800
+48% +$7.73M 0.15% 113
2019
Q2
$16.8M Buy
142,500
+300
+0.2% +$30.2K 0.15% 121
2019
Q1
$12.3M Sell
142,200
-114,900
-45% -$9.78M 0.14% 141
2018
Q4
$16.2M Buy
257,100
+81,600
+46% +$5.6M 0.14% 134
2018
Q3
$13.8M Buy
175,500
+19,800
+13% +$1.29M 0.11% 193
2018
Q2
$9.31M Buy
155,700
+36,200
+30% +$1.95M 0.08% 266
2018
Q1
$4.82M Sell
119,500
-51,400
-30% -$2.51M 0.05% 495
2017
Q4
$8.98M Buy
170,900
+8,600
+5% +$459K 0.06% 383
2017
Q3
$7.65M Sell
162,300
-49,900
-24% -$2.01M 0.07% 347
2017
Q2
$7.51M Sell
212,200
-181,200
-46% -$5.59M 0.08% 306
2017
Q1
$9.29M Buy
393,400
+221,100
+128% +$4.38M 0.11% 217
2016
Q4
$2.3M Buy
172,300
+55,500
+48% +$896K 0.02% 839
2016
Q3
$2.17M Sell
116,800
-164,200
-58% -$2.89M 0.02% 809
2016
Q2
$3.44M Buy
281,000
+175,000
+165% +$1.32M 0.04% 540
2016
Q1
$714K Sell
106,000
-97,600
-48% -$624K 0.01% 1430
2015
Q4
$1.88M Buy
203,600
+91,800
+82% +$854K 0.02% 890
2015
Q3
$2.01M Sell
111,800
-46,900
-30% -$1.08M 0.03% 778
2015
Q2
$4.72M Sell
158,700
-181,400
-53% -$4.56M 0.07% 355
2015
Q1
$7.49M Sell
340,100
-120,600
-26% -$3.06M 0.12% 152
2014
Q4
$12.6M Buy
460,700
+193,100
+72% +$4.7M 0.19% 93
2014
Q3
$5.19M Sell
267,600
-8,400
-3% -$154K 0.08% 281
2014
Q2
$4.7M Sell
276,000
-76,900
-22% -$1.06M 0.07% 323
2014
Q1
$5M Buy
352,900
+169,600
+93% +$2.29M 0.08% 224
2013
Q4
$2.14M Buy
183,300
+59,300
+48% +$680K 0.03% 613
2013
Q3
$1.46M Buy
124,000
+8,200
+7% +$105K 0.03% 742
2013
Q2
$1.61M Buy
+115,800
New +$1.26M 0.04% 538

Other funds holding EXAS

Group One Trading's EXAS Position: Q3 2024 in Review

Group One Trading sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 29,726 shares — an estimated $1.68M sold.

Group One Trading first reported a position in EXAS in Q3 2014 and held it in 28 quarters. The position peaked at $7.54M in Q2 2021. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Group One Trading reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 29,726 Exact Sciences shares in Q3 2024, an estimated $1.68M.
  • Group One Trading first reported a position in Exact Sciences in Q3 2014 and held it in 28 quarters.
  • Group One Trading's Exact Sciences position peaked at $7.54M in Q2 2021.
  • 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.